 |
Trial Management Group
Trial Closed to Accrual
We are very grateful to all participating centres, staff and patients for all their efforts and for their participation in this trial.
|
|
Trial Management Group |
|
Trial Closed to Accrual |
|
| NCIC CTG IND.202 - Randomized Phase II Study of Interleukin-21 (rIL-21) versus Dacarbazine (DTIC) in Patients with Metastatic or Recurrent Melanoma - was closed to accrual on February 29, 2012.
We are very grateful to all participating centres, staff and patients for all their efforts and for their participation in this trial. |